HF
CASI

HRT Financial’s CASI Pharmaceuticals CASI Stock Holding History

HRT Financial’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,535
Closed -$77K – 3262
2021
Q3 		$77K Sell
6,535
-8,738
-57% -$118K ﹤0.01% 2968
2021
Q2 		$236K Buy
+15,273
New +$257K ﹤0.01% 2296
2019
Q3 		– Sell
-1,676
Closed -$53K – 1403
2019
Q2 		$53K Buy
+1,676
New +$53.5K ﹤0.01% 694

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HRT Financial's CASI Position: Q4 2021 in Review

HRT Financial sold out of CASI Pharmaceuticals (CASI) in Q4 2021, closing a stake of 6,535 shares — an estimated $77K sold.

HRT Financial first reported a position in CASI in Q2 2019 and held it in 3 quarters. The position peaked at $236K in Q2 2021. 51 funds tracked by Wall St. Rank hold CASI as of Q4 2021.

  • HRT Financial reported no remaining CASI Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 6,535 CASI Pharmaceuticals shares in Q4 2021, an estimated $77K.
  • HRT Financial first reported a position in CASI Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • HRT Financial's CASI Pharmaceuticals position peaked at $236K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.